Register for our free email digests:
Eli Lilly & Co.
www.lilly.com
Latest From Eli Lilly & Co.
Bayer Sees Room For Third-To-Market Darolutamide In Prostate Cancer
ASCO GU: Darolutamide is important for the company's oncology portfolio, but does it have enough to compete against J&J's Erleada and Pfizer/Astellas' Xtandi?
Glenmark Spins Out Innovation With New US Base
Janssen’s Esketamine Gets US FDA Panel Endorsement, But With Pricing, Access And Diversion Concerns
Committee overwhelmingly supports approval for treatment-resistant depression but warns that pricing and combination therapy indication could hinder patient access. Esketamine’s risks of sedation and dissociative effects, and its abuse potential, will necessitate a strict risk management strategy.
Interview: AC Immune CEO Reflects On Alzheimer's R&D Post-CREAD
The recent failure of the CREAD studies to show a therapeutic effect for crenezumab in Alzheimer’s disease stunned developers. However, an ongoing clinical study of the MAb, and a series of other innovations being explored at Switzerland’s AC Immune, might still provide answers to this intractable condition.
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Cardiovascular
- Infectious & Viral Diseases
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Company Type
- Big Pharma
- Parent & Subsidiaries
-
Eli Lilly & Co.
- Alnara Pharmaceuticals Inc.
- Applied Molecular Evolution Inc.
- Armo BioSciences Inc.
- Avid Radiopharmaceuticals Inc.
- Chorus
- Chugai Lilly Clinical Research Co. Ltd.
- CoLucid Pharmaceuticals Inc.
- Eli Lilly & Co. (India) Pvt. Ltd.
- Eli Lilly Canada Inc.
- Eli Lilly Deutschland GMBH
- Eli Lilly Japan
- Eli Lilly Ranbaxy Ltd.
- Eli Lilly Suzhou Pharmaceutical Group Co. Ltd.
- Hypnion Inc.
- Icos Corp.
- ImClone Systems Inc.
- InnoCentive LLC
- Lilly Research Centre Ltd.
- Lilly Research Laboratories
- Loxo Oncology Inc.
- Medical Devices & Diagnostics
- Pacific Biotech Inc.
- SGX Pharmaceuticals Inc.
- Senior Management
-
David Ricks, CEO
Joshua L Smiley, SVP, CFO
Daniel M Skovronsky, MD, PhD, SVP, CSO - Contact Info
-
Eli Lilly & Co.
Phone: (317) 276-2000
Lilly Corporate Ctr.
Indianapolis, IN 46285
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice